Transdermal fentanyl in palliative care. A series of five cases

Clinical Drug Investigation

Volumn 16, Issue 1, 1998, Pages 88-91

  O'Síoráin, Liam ^a  

^a Our Lady's Hospice Ltd Dublin   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; MORPHINE;

ADULT; AGED; ANALGESIA; ARTICLE; BONE METASTASIS; CANCER PAIN; CLINICAL ARTICLE; DYSPNEA; FEMALE; HOSPICE; HUMAN; MALE; OVARY CANCER; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROSTATE CANCER; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0031878258     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199816010-00014     Document Type: Article

References (2)

1. Ahmedzai S. Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. J Pain Symptom Manage 1997 May; 13 (5): 254-61
2. Portenoy RK. Southam MA. Gupta SK. et al. Transdermal fentanyl for cancer pain. Repealed dose pharmacokinetics. Anesthesiology 1993; 78: 36-43